Exploring the Versatility of Cyanuric Chloride: Synthesis, Characterization, and Potential Applications of Triazine Based Derivatives

Abstract

Organic chemistry plays a transformative role in the medical field, where the development of new molecules and innovative approaches has driven progress in drug discovery and disease treatment. As researchers continually seek novel therapeutic agents, compounds with unique structural properties and dynamic functionality are of high interest. Cyanuric chloride, a triazine-based reagent, stands out in this regard. Its stability and electrophilic nature, which allow sequential substitution by various nucleophiles, make it well-suited for diverse synthetic applications. Previous work in this research group developed novel triazine-based compounds that show promising effects in suppressing the progression of Diabetic Nephropathy (DN). This has motivated the synthesis of analogues with greater tunability for enhanced clinical activity. Herein, cyanuric chloride is utilized as a core reagent for nucleophilic substitutions. Pyrimidines - Uracil, thymine, and cytosine-propanehydrazides, chosen for their role as nucleic bases naturally present in the human body, are introduced to functionalize the cyanuric chloride, thereby creating compounds with potentially improved biocompatibility. Additionally, tert-butyl carbazate is used as a versatile substrate, allowing further functionalization of the synthesized molecule, enhancing its potential for post-synthetic modifications and adaptability for more targeted interventions. The choice of nucleophiles, together with the multifunctional capability, enables the synthesis of structurally diverse and biologically significant molecules. By integrating these components, in this research we aim to synthesize novel molecules that incorporate the robust framework of cyanuric chloride with nucleic base derivatives and tert-butyl carbazate. Structural characterization using Nuclear Magnetic Resonance (NMR), Fourier-Transform Infrared Spectroscopy (FTIR), and ThermoGravimetric Analysis (TGA), confirms the identity and purity of the synthesized molecules. Given the structural and functional properties of the synthesized molecules, they hold promise for applications in the treatment or management of diseases, with potential impacts in areas such as diabetes and cancer. This study thus contributes to the ongoing exploration of cyanuric chloride derivatives in medicinal chemistry, offering insights into their structural versatility and applicability in designing new pharmaceutical compounds.